New Leaf Venture Partners

New Leaf Venture Partners

A venture capital firm in New York focused on investments in healthcare technology companies

New Leaf Venture Partners is a venture capital firm in New York focused on investments in healthcare technology companies. Founded 2005 in New York, United States by James Niedel, Jeani Delagardelle, Philippe Chambon, Ronald Hunt, and Vijay Lathi, this venture capital firm invests in debt, early stage ventures, late stage ventures and private equity. Its portfolio companies include Iterum Therapeutics, Aptinyx, Kyruus, AiCure, and Edgewise Therapeutics. As of February 2020, New Leaf Venture Partners has made 155 investments. Their most recent investment was on Nov 7, 2019, when AiCure raised $24.5M. New Leaf Venture Partners has had 39 exits, the most notable of which include Alector, Aptinyx, and Wave Life Sciences. The company has raised four funds, their latest being New Leaf Ventures IV. The company specifically focuses on later stage biopharmaceutical products, early stage medical devices, and laboratory infrastructure technologies.

Timeline

2005
Founded

Funded Companies

Company
Description
Industry
Website
Location
Aicure

AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.

U.S-based company providing a platform to match patients with the right healthcare personnel.

A company developing products to treat respiratory diseases, including chronic obstructive pulmonary disease

A technology company offering an internet of things (IoT) platform for the biopharmaceutical and medical technology industries.

Kit Check is a Washington, D.C.-based provider of a cloud software platform for automated hospital pharmacy and medication processing and tracking.

A company developing diagnostic monitoring solutions for early diagnosis and treatment of cardiac arrhythmia

A company developing treatments for genetic disorders associated with the liver

A company that provides cell and tissue based diagnostic tests for personalized medicine development

Nested is a London-based company founded by Matt Robinson, James Turford and Phil Cowans.

A biopharmaceutical company developing drugs to treat cardiovascular and renal diseases

Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases.

Passage Bio, Inc is a Philadelphia-based biotechnology company developing genetics-based medicines.

Edgewise Therapeutics is a drug discovery and biotechnology company developing products based on the understanding of skeletal muscle.

A biopharmaceutical company developing oral small molecule therapies for the treatment of cancer and autoimmune diseases

DiCE Molecules is a Redwood City, California-based company.

Access Closure is a Santa Clara, California-based healthcare company.

A company developing cancer therapeutics

CardioKinetix is a Menlo Park, California-based company.

IlluminOss Medical is a East Providence, Rhode Island-based healthcare company founded by Arnold Peter Weiss.

28 Results
Results per page:
Page 1 of 2

People

Name
Role
LinkedIn

Christina Kim

Analyst

Dan Becker

Principal

Philippe Chambon

Managing Director and founder

Rebecca Luse

Vice President

Ron Hunt

Managing Director

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

AiCure

BrightInsight

CuraSen Therapeutics

Edgewise Therapeutics

Harpoon Therapeutics

Passage Bio

Qlaris Bio

Renovacor

TigerConnect

News

Title
Author
Date
Publisher
Description
AlleyWatch
October 10, 2020
AlleyWatch
The Pulse of New York Tech

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.